The effects of zinc methionine on reproductive and thyroid hormones in rats with polycystic ovarian syndrome


1 Department of Animal Science, Science and Research Branch, Islamic Azad University, Tehran, Iran

2 Department of Animal Sciences, Islamic Azad University, Golpayegan Branch, Isfahan, Iran

3 Department of Parasitology and Mycology, Skin Disease and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Animal Sciences, Ferdowsi University of Mashhad, Mashhad, Iran


Background: Polycystic ovarian syndrome (PCOS) is an endocrine disorder in fertile women, which seems to be adversely affected by associated thyroid dysfunction. Zinc methionine (ZM) has positive effects on PCOS, but its concerted effects on PCOS and thyroid function have not been investigated. We evaluated the effects of ZM on reproductive and thyroid hormones and the number of follicles in rats with PCOS. Materials and Methods: This study was conducted on 45 female rats, using sesame oil as control; PCOS animals administered with 0, 25, 75, and 175 mg/kg BW of ZM. Serum concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid function were investigated. Premature follicles (PMF), primary follicles (PF), preantral follicles (PAF), antral follicles (AF), corpus luteum (CL), and cystic follicles (CF) were assessed. Results: PCOS decreased the concentrations of FSH and free T4, but increased the levels of LH, TSH, and LH/FSH ratio (ALL P < 0.05). ZM at a dose of 75 and 175 mg increased the level of FSH, free T4, and decreased LH, TSH, and LH/FSH ratio (ALL P < 0.05). Induction of PCOS decreased PMF, PF, PAF, AF, and CL, but increased CF (P < 0.05). PCOS treated groups (75 and 175 mg/kg) increased these follicle numbers and decreased CF compared to ZM 25 mg/kg and PCOS groups (Both P < 0.05). Conclusions: Although the induction of PCOS had a negative effect on reproductive and thyroid hormones and follicle numbers, ZM treatment (75 and 175 mg/kg) overcame the negative effects. A high dosage of ZM can alleviate the hormonal and cysts disturbances occurring in PCOS.


Huang W, Li S, Luo N, Lu K, Ban S, Lin H. Dynamic analysis of the biochemical changes in rats with polycystic ovary syndrome (PCOS) using urinary 1H NMR-based metabonomics. Horm Metab Res 2020;52:49-57.  Back to cited text no. 1
Zhang HL, Yi M, Li D, Li R, Zhao Y, Qiao J. Transgenerational inheritance of reproductive and metabolic phenotypes in PCOS rats. Front Endocrinol (Lausanne) 2020;11:144.  Back to cited text no. 2
Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab 2013;17:304-9.  Back to cited text no. 3
Rodriguez Paris V, Bertoldo MJ. The Mechanism of Androgen Actions in PCOS Etiology. Med Sci (Basel) 2019;7:89-100.  Back to cited text no. 4
Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 2019;3:1545-73.  Back to cited text no. 5
Palomba S, Daolio J, La Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrinol Metab 2017;28:186-98.  Back to cited text no. 6
Huang J, Liu L, Chen C, Gao Y. PCOS without hyperandrogenism is associated with higher plasma trimethylamine N-oxide levels. BMC Endocr Disord 2020;20:3.  Back to cited text no. 7
Elslimani FA, Elhasi M, Elmhdwi MF. The relation between hypothyroidism and polycystic ovary syndrome. J Pharm Appl Chem 2016;2:197-200.  Back to cited text no. 8
Shirsath A, Aundhakar N, Kamble P. Does the thyroid hormonal levels alter in polycystic ovarian disease? A comparative cross sectional study. Indian J Basic Appl Med Res 2015;4:265-71.  Back to cited text no. 9
Sethi P. Evaluation of serum prolactin, FSH and LH levels in women with thyroid disorders: A hospital based study. Indian J Appl Res 2016;6:460-2.  Back to cited text no. 10
Gabersˇcˇek S, Zaletel K, Schwetz V, Pieber T, Pietsch BO, Lerchbaum E. Thyroid and polycystic ovary syndrome. Eur J Endocrinol 2015;172:R9-21.  Back to cited text no. 11
Fazel Torshizi F, Chamani M, Khodaei HR, Sadeghi AA, Hejazi SH, Majidzadeh Heravi R. Therapeutic effects of organic zinc on reproductive hormones, insulin resistance and mTOR expression, as a novel component, in a rat model of polycystic ovary syndrome. Iran J Basic Med Sci 2020;23:36-45.  Back to cited text no. 12
Huang D, Hu Q, Fang S, Feng J. Dosage effect of zinc glycine chelate on zinc metabolism and gene expression of zinc transporter in intestinal segments on rat. Biol Trace Elem Res 2016;171:363-70.  Back to cited text no. 13
Nagalakshmi D, Sridhar K, Parashuramulu S. Replacement of inorganic zinc with lower levels of organic zinc (zinc nicotinate) on performance, hematological and serum biochemical constituents, antioxidants status, and immune responses in rats. Vet World 2015;8:1156-62.  Back to cited text no. 14
De Souza AR, Martins LP, De Faria LC, Martins ME, Fereira RN, De Silva AM, et al. Studies on the bioavailability of zinc in rats supplementated with two different zinc-methionine compounds. Lat Am J Pharm 2007;26:825-30.  Back to cited text no. 15
Koppa NA, Jatmika C. Synthesis and analysis of zinc-methionine, zinc-tryptophan, copper-lysine, and copper-isoleucine complexes using atomic absorption spectrophotometry. Int J App Pharm 2018;10:416-8.  Back to cited text no. 16
Guler I, Himmetoglu O, Turp A, Erdem A, Erdem M, Onan MA, et al. Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance. Biol Trace Elem Res 2014;158:297-304.  Back to cited text no. 17
Severo JS, Morais JB, de Freitas TE, Andrade AL, Feitosa MM, Fontenelle LC, et al. The role of zinc in thyroid hormones metabolism. Int J Vitam Nutr Res 2019;89:80-8.  Back to cited text no. 18
Pournaderi PS, Yaghmaei P, Khodaei H, Noormohammadi Z, Hejazi SH. The effects of 6-Gingerol on reproductive improvement, liver functioning and cyclooxygenase-2 gene expression in estradiol valerate-Induced polycystic ovary syndrome in wistar rats. Biochem Biophys Res Commun 2017;484:461-6.  Back to cited text no. 19
Pohlenz J, Maqueem A, Cua K, Weiss RE, Van Sande J, Refetoff S. Improved radioimmunoassay for measurement of mouse thyrotropin in serum: Strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid 1999;9:1265-71.  Back to cited text no. 20
Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What's new? Adv Clin Exp Med 2017;26:359-67.  Back to cited text no. 21
Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome-a hypothesis. J Endocrinol 2002;174:1-5.  Back to cited text no. 22
Soni A, Singla S, Goyal S. Polycystic ovary syndrome: Pathogenesis, treatment and secondary diseases. J Drug Deliv Ther 2018;8:107-12.  Back to cited text no. 23
Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 2016;37:467-520.  Back to cited text no. 24
Teede HJ, Hutchison S, Zoungas S, Meyer C. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 2006;30:45-53.  Back to cited text no. 25
Al-Juaifari B, Al-Jumaili E. Correlation of body mass index and some hormones (estradiol, luteinizing, follicle stimulating hormones) with polycystic ovary syndrome among young females [20-35 years]. Biomed Pharmacol J 2020;13:193-8.  Back to cited text no. 26
Sauer AK, Hagmeyer S, Grabrucker AM. Zinc deficiency. In: Erkekoglu P, Kocer-Gumusel B, editors. Nutritional Deficiency. London, UK: InTechOpen. 2016. p. 23-46.  Back to cited text no. 27
Bakheet M, Almarshad H. Improving effect of zinc supplementation in pituitary gonadotropins secretion in smokers. Afr J Pharm Pharmacol. 2014;8:81-6.  Back to cited text no. 28
Baravalle C, Salvetti NR, Mira GA, Pezzone N, Ortega HH. Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res 2006;37:830-9.  Back to cited text no. 29
Harlow CR, Shaw HJ, Hillier SG, Hodges JK. Factors influencing follicle-stimulating hormone-responsive steroidogenesis in marmoset granulosa cells: Effects of androgens and the stage of follicular maturity. Endocrinology 1988;122:2780-7.  Back to cited text no. 30
Rice S, Ojha K, Whitehead S, Mason H. Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-Müllerian hormone type II receptor in single, isolated, human preantral follicles: Relevance to polycystic ovaries. J Clin Endocrinol Metab 2007;92:1034-40.  Back to cited text no. 31
Franks S, Hardy K. Androgen action in the ovary. Front Endocrinol (Lausanne) 2018;9:452.  Back to cited text no. 32
Yang H, Lee SY, Lee SR, Pyun BJ, Kim HJ, Lee YH, et al. Therapeutic effect of ecklonia cava extract in letrozole-induced polycystic ovary syndrome rats. Front Pharmacol 2018;9:1325.  Back to cited text no. 33
Murugesan MB, Muralidharan P, Hari R. Effect of ethanolic seed extract of Caesalpinia bonducella on hormones in mifepristone induced PCOS rats. J Appl Pharm Sci 2020;10:72-6.  Back to cited text no. 34
Shanmugham D, Natarajan S, Karthik A. Prevalence of thyroid dysfunction in patients with polycystic ovarian syndrome: A cross sectional study. Int J Reprod Contracept Obstet Gynecol 2018;7:3055-9.  Back to cited text no. 35
Moustafa MM, Jamal MY, Al-Janabi RD. Thyroid hormonal changes among women with polycystic ovarian syndrome in Baghdad-a case-control study. F1000Research 2019;8:1-14.  Back to cited text no. 36